- Home
- IOBT vs TOI Comparison
IOBT vs TOI Comparison
Compare IOBT & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- TOI
- Stock Information
- Founded
- IOBT 2014
- TOI 2007
- Country
- IOBT Denmark
- TOI United States
- Employees
- IOBT N/A
- TOI N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- IOBT Health Care
- TOI Health Care
- Exchange
- IOBT Nasdaq
- TOI Nasdaq
- Market Cap
- IOBT 57.9M
- TOI 49.1M
- IPO Year
- IOBT 2021
- TOI N/A
- Fundamental
- Price
- IOBT $1.16
- TOI $1.06
- Analyst Decision
- IOBT Strong Buy
- TOI
- Analyst Count
- IOBT 3
- TOI 0
- Target Price
- IOBT $9.33
- TOI N/A
- AVG Volume (30 Days)
- IOBT 213.3K
- TOI 529.3K
- Earning Date
- IOBT 05-13-2025
- TOI 03-24-2025
- Dividend Yield
- IOBT N/A
- TOI N/A
- EPS Growth
- IOBT N/A
- TOI N/A
- EPS
- IOBT N/A
- TOI N/A
- Revenue
- IOBT N/A
- TOI $393,412,000.00
- Revenue This Year
- IOBT $59.29
- TOI $23.95
- Revenue Next Year
- IOBT N/A
- TOI N/A
- P/E Ratio
- IOBT N/A
- TOI N/A
- Revenue Growth
- IOBT N/A
- TOI 21.33
- 52 Week Low
- IOBT $0.66
- TOI $0.13
- 52 Week High
- IOBT $1.79
- TOI $1.63
- Technical
- Relative Strength Index (RSI)
- IOBT 67.95
- TOI 74.78
- Support Level
- IOBT $0.90
- TOI $0.63
- Resistance Level
- IOBT $1.37
- TOI $0.99
- Average True Range (ATR)
- IOBT 0.10
- TOI 0.11
- MACD
- IOBT 0.03
- TOI 0.05
- Stochastic Oscillator
- IOBT 60.97
- TOI 84.17
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.